Browsing Tag
Novo Nordisk
79 posts
Novo Nordisk announces significant outcomes for Mim8 in FRONTIER 2 trial
Novo Nordisk, a global healthcare leader, has announced significant outcomes from the FRONTIER 2 trial, a pivotal phase…
Novo Nordisk to acquire Cardior Pharmaceuticals to expand cardiovascular portfolio
In a significant move within the pharmaceutical industry, Novo Nordisk has agreed to acquire Cardior Pharmaceuticals for up…
FDA approves Novo Nordisk’s Wegovy for cardiovascular risk reduction in adults with obesity
The U.S. Food and Drug Administration (FDA) has recently granted an additional indication for Novo Nordisk’s Wegovy, a…
Novo Nordisk announces $11bn acquisition of fill-finish sites to boost global manufacturing
In a strategic move to enhance its global manufacturing capabilities, Novo Nordisk has announced a significant acquisition from…
Novo Nordisk announces major expansion of Chartres manufacturing site in France
Novo Nordisk, a global healthcare leader, has announced a significant investment exceeding 16 billion Danish kroner (2.1 billion…
Novo Nordisk acquires Embark Biotech and enters R&D collaboration to advance obesity treatments
Novo Nordisk, a global leader in healthcare, has acquired Embark Biotech, including its lead metabolic program, in a…
Novo Nordisk to acquire Canadian pharma company Inversago Pharma
Danish pharma major Novo Nordisk A/S has confirmed its plan to acquire Montreal-based Inversago Pharma. The potential cash…
Novo Nordisk commits $2.3bn for expansion of Danish API production plant
Novo Nordisk, a Danish pharmaceutical firm, has declared its intention to funnel DKK 15.9 billion ($2.3 billion) into…
Rigel Pharmaceuticals gets Rezlidhia FDA approval for AML
Rigel Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its Rezlidhia (olutasidenib) capsules…
Novo Nordisk acquires SCD drug developer Forma Therapeutics
Novo Nordisk acquisition of Forma Therapeutics : Danish pharma company Novo Nordisk has closed the previously announced $1.1…